| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |